Clinical Implication of Mutifocality for Risk of Recurrence in Patients With Papillary Thyroid Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Multifocality is frequently detected in papillary thyroid cancer (PTC). However, the prognostic significance of multifocality in PTC remains controversial. This study aimed to investigate the prognostic significance of multifocality in PTC. Methods: We assessed 1,577 patients with PTC who underwent thyroid lobectomy from January 2008 to December 2016 at Seoul St. Mary’s Hospital (Seoul, Korea). The clinicopathological characteristics and long-term oncologic outcomes between multifocality and unifocality with PTC were compared. The mean follow-up duration was 97.2±20.0 months. Results: Multifocality was observed in 290 (19.1%) patients. Compared with unifocality, multifocality had a significantly higher prevalence of extrathyroidal extension (ETE), vascular invasion, and more advanced N and TNM stages. The recurrence rate was significantly higher in multifocality than in unifocality (P=0.034). Multifocality was identified as a significant risk factor for disease-free survival (DFS) in the multivariate analysis (hazard ratio, 1.895; P=0.043). In the Kaplan–Meier analysis, a significant difference was noted in the DFS between the multifocality and unifocality groups (log-rank P=0.017). Conclusion: Multifocality is associated with an increased risk of recurrence. This suggests that multifocality in PTC is a significant predictor of oncologic outcomes. Therefore, we suggest that patients with multifocality receive careful treatment from the initial evaluation to surgery and postoperative period.
Abstract
Purpose: Multifocality is frequently detected in papillary thyroid cancer (PTC). However, the prognostic significance of multifocality in PTC remains controversial. This study aimed to investigate the prognostic significance of multifocality in PTC. Methods: We assessed 1,577 patients with PTC who underwent thyroid lobectomy from January 2008 to December 2016 at Seoul St. Mary’s Hospital (Seoul, Korea). The clinicopathological characteristics and long-term oncologic outcomes between multifocality and unifocality with PTC were compared. The mean follow-up duration was 97.2±20.0 months. Results: Multifocality was observed in 290 (19.1%) patients. Compared with unifocality, multifocality had a significantly higher prevalence of extrathyroidal extension (ETE), vascular invasion, and more advanced N and TNM stages. The recurrence rate was significantly higher in multifocality than in unifocality (P=0.034). Multifocality was identified as a significant risk factor for disease-free survival (DFS) in the multivariate analysis (hazard ratio, 1.895; P=0.043). In the Kaplan–Meier analysis, a significant difference was noted in the DFS between the multifocality and unifocality groups (log-rank P=0.017). Conclusion: Multifocality is associated with an increased risk of recurrence. This suggests that multifocality in PTC is a significant predictor of oncologic outcomes. Therefore, we suggest that patients with multifocality receive careful treatment from the initial evaluation to surgery and postoperative period.
참고문헌 (28)
- James BC, "An update in international trends in incidence rates of thyroid cancer, 1973-2007", Cancer Causes Control, 29, pp.465~473 (2018)
- Li M, "Global trends in thyroid cancer incidence and the impact of overdiagnosis", Lancet Diabetes Endocrinol, 8, pp.468~470 (2020)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016", Cancer Research and Treatment, 51(2), pp.417~430 (2019), 대한암학회
- Pereira M, "Thyroid cancer incidence trends in the United States : association with changes in professional guideline recommendations", Thyroid, 30, pp.1132~1140 (2020)
- Park S, "Association between screening and the thyroid cancer"epidemic"in South Korea : evidence from a nationwide study", BMJ, 355, pp.i5745~ (2016)
- Ahn HS, "Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality", Thyroid, 26, pp.1535~1540 (2016)
- Colonna M, "Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France", Cancer Epidemiol, 39, pp.511~518 (2015)
- 전민지, "Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study", Endocrinology and Metabolism, 32(4), pp.434~441 (2017), 대한내분비학회
- Cho BY, "Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades", Thyroid, 23, pp.797~804 (2013)
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26, pp.1~133 (2016)
- Kim HJ, "Multifocality, but not bilaterality, is a predictor of disease recurrence", persistence of papillary thyroid carcinoma, 2013, pp.37, 376~384
- Kim KJ, "Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size : a retrospective study of 2, 309 consecutive patients", Ann Surg Oncol, 22, pp.125~131 (2015)
- Wang F, "The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer", J Clin Endocrinol Metab, 102, pp.3241~3250 (2017)
- Joseph KR, "Multifocality as a prognostic factor in thyroid cancer : A meta-analysis", Int J Surg, 50, pp.121~125 (2018)
- Markovic I, "Multifocality as independent prognostic factor in papillary thyroid cancer-A multivariate analysis", J BUON, 23, pp.1049~1054 (2018)
- Guo K, "Risk factors influencing the recurrence of papillary thyroid carcinoma : a systematic review and meta-analysis", Int J Clin Exp Pathol, 7, pp.5393~5403 (2014)
- Kuhn E, "Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature", Endocr Pathol, 23, pp.101~107 (2012)
- Shattuck TM, "Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma", N Engl J Med, 352, pp.2406~2412 (2005)
- Wang W, "Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas", Hum Pathol, 41, pp.1299~1309 (2010)
- Lupoli G, "Familial papillary thyroid microcarcinoma : a new clinical entity", Lancet, 353, pp.637~639 (1999)
- Pessôa-Pereira D, "Association between BRAF(V600E)mutation and clinicopathological features of papillary thyroid carcinoma : a Brazilian single-centre case series", Arch Endocrinol Metab, 63, pp.97~106 (2019)
- Kaliszewski K, "Obesity and overweight are associated with minimal extrathyroidal extension, multifocality and bilaterality of papillary thyroid cancer", J Clin Med, 10, pp.970~ (2021)
- Shi X, "Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants", J Clin Endocrinol Metab, 101, pp.264~274 (2016)
- McCarthy RP, "Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas", Clin Cancer Res, 12, pp.2414~2418 (2006)
- Geron Y, "Multifocality is not an independent prognostic factor in papillary thyroid cancer : a propensity score–matching analysis", Thyroid, 29, pp.513~522 (2019)
- Woo J, "Impact of multifocality on the recurrence of papillary thyroid carcinoma", J Clin Med, 10, pp.5144~ (2021)
- Neuhold N, "Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential : a retrospective clinicopathological study with up to 30 years of follow-up", Ann Surg Oncol, 18, pp.3430~3436 (2011)
- Grogan RH, "A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up", Surgery, 154, pp.1436~1446 (2013)